EXTRACELLULAR NUCLEOTIDES such as ATP mediate a number of cell processes through interaction with specific P2Y receptors (33, 45) . P2Y receptors are expressed by a number of tissues and regulate diverse processes including vasomotor responses (37) , neurotransmission (3), platelet aggregation (16, 23) , and secretion (13, 38, 42) . In epithelial cells, P2Y receptors are linked specifically to fluid and electrolyte secretion independent of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) (12, 49) . For this reason, activation of P2Y receptors has been proposed as a therapy for CF (19, 20) .
Multiple subtypes of P2Y receptors are found in mammals, and they are distinguished both by molecular identity and by pharmacological activation (33) . In the rat, four P2Y receptors have been identified, designated P2Y 1 (43) , P2Y 2 (10), P2Y 4 (4) , and P2Y 6 (8) . Although P2Y 2 and P2Y 4 are activated by both ATP and UTP, P2Y 1 is activated by ADP (and to a lesser extent ATP) and P2Y 6 is activated only by UDP. Distinct combinations of P2Y subtypes are found in different epithelial tissues and may allow tissue-specific regulation of nucleotide responses. Moreover, some tissues differentially express specific P2Y receptor subtypes at apical and/or basolateral plasma membranes (22, 25, 47) .
Several lines of evidence indirectly suggest that stimulation of nucleotide receptors may mediate secretion in the liver. Nucleotide release mediates communication from hepatocytes to cholangiocytes in cocultures of isolated cells (39) . Furthermore, ATP and other nucleotides are found in bile at concentrations that can activate P2Y receptors (9) . Finally, P2Y receptors are found on apical membranes in biliary epithelial cell lines (36, 38) . Together, these data suggest that hepatocytes may signal to cholangiocytes through release of nucleotides into bile followed by activation of P2Y receptors at the luminal (apical) membrane. In addition, cholangiocytes also express basolateral P2Y receptors (29) , which may mediate signaling from neural or vascular tissue. Thus the goal of this study was to define the expression and subcellular distribution of P2Y subtypes in bile duct epithelia and to determine the relative roles of apical and basolateral receptors in mediating functional activation of cholangiocytes.
METHODS

Animals and materials.
Male Sprague-Dawley rats (180-250 g; Harlan Sprague-Dawley, Indianapolis, IN) were used for cholangiocyte isolations. Male Fisher 344 rats (225-250 g; Harlan Sprague-Dawley) were used for intrahepatic bile duct isolation. ATP, ADP, 2-methylthioadenosine 5Ј-triphosphate (2-MeS-ATP), adenosine 5Ј-O-(3-thiotriphosphate) (ATP-␥-S), ␣,␤-methyleneadenosine 5Ј-triphosphate (␣,␤-MeATP), ␤,␥-methyleneadenosine 5Ј-triphosphate (␤,␥-MeATP), 2Ј-and 3Ј-O-(4-benzoylbenzoyl)adenosine 5Ј-triphosphate (BzATP), UTP, UDP, ACh, suramin, apyrase, and 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-AM were obtained from Sigma Chemical (St. Louis, MO). Fluo 4-AM and 2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) dextran were obtained from Molecular Probes (Eugene, OR). All other chemicals were of the highest quality commercially available.
Buffer composition. The composition of isotonic (290 mosmol/kgH 2O) Krebs-Ringer-bicarbonate buffer (KRB) was (in mM) 120.0 NaCl, 5.9 KCl, 1.2 Na 2HPO4, 1.0 MgSO4, 25.0 NaHCO 3, 1.25 CaCl2, and 5.0 glucose. For HCO 3 Ϫ transport experiments, the perfusion buffer contained 140 mM NaCl, 5 mM Na 2HPO4, and 25-100 M BCECF dextran, pH 7.2.
Preparation of single rat bile duct cells. Single cholangiocytes were prepared and characterized in the Cell Isolation and Morphology Core Facilities of the Yale Liver Center as described previously (40) . This preparation results in a bile duct epithelial preparation that is ϳ98% pure as assessed by positive staining for the biliary epithelial markers ␥-glutamyl transpeptidase, cytokeratin-19, and cytokeratin-7 (1, 34) . Experiments using single bile duct cells were performed 12 h after plating.
RT-PCR. P2Y receptor subtypes in cholangiocytes were detected using two-step RT-PCR performed on RNA from freshly isolated bile duct cells. Bile duct cell total RNA was extracted using TRIzol reagent (Life Technologies, Rockville, MD). RNA was analyzed by electrophoresis and spectrophotometry and treated with RNase-free DNase (RQ1, Promega, Madison, WI) for 15 min at 37°before RT-PCR. First-strand cDNA was prepared according to manufacturer's instructions using Moloney murine leukemia virus reverse transcriptase and a 1:1 mixture of random hexamer and oligo(dT)18 primers (Advantage RT-for-PCR; Clontech, Palo Alto, CA). Firststrand cDNA was used as a template for specific amplification of primers for P2Y subtypes P2Y1, P2Y2, P2Y4, and P2Y6 using the following primer pairs: P2Y1, 5Ј-TGG CGT GGT  GCT GCA CCC TCT CAA GCT-3Ј and 5Ј-CGG GAC AGT  CTC CTT CTG AAT GTA-3Ј; P2Y2, 5Ј-CTG CCA GGC ACC  CGT GCT CTA CTT-3Ј and 5Ј-CTG AGG TCA AGT GAT  CGG AAG GAG-3Ј; P2Y4, 5Ј-CAC CGA TAC CTG GGT ATC  TGC CAC-3Ј and 5Ј-CAG ACA GCA AAG ACA GTC AGC  ACC-3Ј; P2Y6, 5Ј-GGA GAC CTT GCC TGC CGC TGC CGC  CTG GTA-3Ј and 5Ј-TAC CAC GAC AGC CAT ACG GGC  CGC-3Ј(44); P2X1, 5Ј-AGG CCG TGT GGG GTG TTC ATC  TC-3Ј and 5Ј-ACC TTG GGC TTT CCT TTC TGC TTT TC-3Ј; P2X2, 5Ј-GAG GCG GGT CAA GGG CGG TCT G-3Ј and 5Ј-GGG GTC TTG GGA TCC TGC ATT ACT TG-3Ј; P2X 3, 5Ј-ACC GGC CGC TGC GTG AAC TAC A-3Ј and 5Ј-AAG GCC GCC ACC GAG CTG ATA TG-3Ј; P2X4, 5Ј-GAT CTG GGA CGT GGC GGA CTA TGT GA-3Ј and 5Ј-TAT GGG GCA GAA GGG ATC CGT TTG AG-3Ј; P2X5, ATG GCG AGT GTT CTG AGG ACC ATC AC-3Ј and 5Ј-TGC CCC TGC CCA GCG GAC AAT AGA C-3Ј; P2X6, 5Ј-CGC ATC GGG GAC CTT GTG G-3Ј and 5Ј-ATC CCG GCA TCA GCA GAC G; P2X7, CTT CGG CGT GCG TTT TGA CAT CC-3Ј and 5Ј-AGG GCC CTG CGG TTC TCT GGT AGT T-3Ј. PCR reactions were amplified with Advantage cDNA polymerase mix (Clontech) using the following cycling parameters: 94°ϫ 1 min; 30 cycles [94°ϫ 30 s, 60°(63°for P2Y4) ϫ 30 s, 72°ϫ 1 min]; 72°ϫ 5 min. Expected product size ranged from 300 to 600 bp. Control reactions were performed with DNase-treated RNA that was treated either with RNA but not RT as a template (RNA controls), to eliminate the possibility of genomic DNA contamination, or water rather than RNA as a template (water controls), to eliminate the possibility of reagent contamination. Products were analyzed by gel electrophoresis and sequenced to verify their identity.
Microperfusion of microdissected rat intrahepatic bile duct units. Individual microdissected rat intrahepatic bile duct units (IBDUs) were prepared, perfused, and observed as described previously (27) . Briefly, concentric glass pipettes were used to cannulate both lumens of the IBDU, and the apparatus was transferred to a special stage for use with a fluorescence microscope (see Measurement of nucleotide-induced changes in cytosolic Ca 2ϩ in IBDUs). Solutions were delivered near the tip of the perfusion pipette through a fluid exchange pipette filled by a variable-speed syringe pump (Harvard Apparatus, Holliston, MA) with a 1-ml gas-tight syringe (Hamilton, Oceanside, CA). When perfusing solutions were switched for apical perfusion studies, the initial perfusion apparatus was stopped, emptied, and then refilled with the subsequent perfusion solution. The IBDU perfusion rate was then recalibrated. IBDUs were perfused at rates of from 10 to 120 nl/min.
The external surfaces of IBDUs were bathed simultaneously in a buffer whose composition was continuously controlled. The bath solution was stirred and oxygenated with a 5% O 2-95% CO2 gas mixture. Fluid temperature was maintained at 37°with a temperature controller (Digi-Sense; Cole Parmer, Vernon Hills, IL). IBDUs were equilibrated for up to 30 min before the start of each experimental protocol. ) in cholangiocytes were detected using the cell-permeant Ca 2ϩ -sensitive fluorescent indicator fluo 4-AM. After dissection and perfusion as described in Microperfusion of microdissected rat intrahepatic bile duct units, IBDUs were luminally perfused with fluo 4-AM (24 M) for 30 min at 37°C. A fluorescence illuminator (90720 TE epifluorescence attachment for Nikon TE 300 microscope) was specially modified by the Mayo Division of Engineering to detect fluorescence changes from a fixed-size aperture. Fluorescence was detected from a 100-m-diameter circular spot within a region of cytosolic fluorescence in an IBDU by a photosensor module (H5784; Hamamatsu Photonics, Bridgewater, NJ). Background fluorescence and autofluorescence were negligible with this system. The signal was digitized by a data-acquisition board (PCI-6023E; National Instruments, Austin, TX) using a PCtype computer. A custom-modified software application (LabView 5.1; National Instruments) was used to control data acquisition and display data during each experiment and to output the data to a spreadsheet for analysis. Data samples were collected 10 times/s. Apical P2Y and P2X receptors were stimulated by perfusion of nucleotides into the duct lumen, whereas basolateral P2Y and P2X receptors were stimulated by addition of nucleotides to the perifusing bath fluid. Fluorescence values were expressed as percentage of baseline.
Measurement of nucleotide-induced changes in cytosolic
Data analysis of Ca i 2ϩ changes. Each experiment was graphed separately with a spreadsheet program, with time as the x-axis and raw fluorescence as the y-axis. Baseline and peak values were identified manually. Baseline fluorescence was defined as a plateau of fluorescence lasting Ն5 s immediately before addition of agonist. Experiments were not performed unless a constant baseline of 10-20 s was identified before experimental runs. Isolated fluorescence peaks lasting Յ1 s were disregarded to eliminate the possibility of artifactual fluorescence increases. Fluorescence increases for each individual experiment were expressed as a peak-tobaseline fluorescence ratio.
Measurement of nucleotide-induced changes in pH in IBDUs.
The luminal pH of perfused IBDUs was measured by using the cell-impermeant pH-sensitive dye BCECF dextran and the quantitative epifluorescence approach described above (27) . The IBDUs were perfused with HCO 3 Ϫ -free buffer containing BCECF dextran (pH 7.2) and simultaneously bathed with KRB or HCO 3 Ϫ /CO2-free buffer (pH 7.4). Luminal dye was excited alternately at 495 Ϯ 10 nm and 440 Ϯ 10 nm wavelengths, and emission was monitored as described above. In situ calibration curves were generated to convert fluorescence excitation ratios (F 495/F440) to pH values.
Statistics. Changes in fluo 4 fluorescence ratio and pH are expressed as means Ϯ SE. Comparisons between groups were made using Student's t-test. A P value of Ͻ0.05 was taken as significant.
RESULTS
Rat cholangiocytes express multiple P2 receptor subtypes. Molecular expression of P2Y receptor subtypes in freshly isolated rat cholangiocytes was determined by RT-PCR. Oligonucleotide primers specific to the four P2Y subtypes cloned in rat (33, 44) were used. Cholangiocytes expressed all four of these P2Y subtypes ( Fig.  1 ), which were absent in RNA and water controls. Similar results were found in freshly isolated rat hepatocytes (not shown). These results are in contrast to findings in the normal rat cholangiocyte (NRC) cell line, in which the only P2Y receptor molecularly identified was the P2Y 2 receptor (38) . Because nucleotideinduced increases in Ca i 2ϩ could be induced by P2X ligand-gated ion channels as well as P2Y G proteincoupled receptors, we tested for the presence of P2X receptors in rat cholangiocytes. Molecular expression of P2X receptors was examined using RT-PCR of immunoisolated rat cholangiocytes with oligonucleotide probes specific for rat P2X subtypes P2X 1-7 (see Fig.  6A ). Cholangiocytes expressed only the P2X 4 subtype. Positive control PCR products were expressed using either total liver (P2X 1-7 ) or heart (P2X 1,2,4,5 ) (not shown). Together, these data show that rat cholangiocytes express P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 6 receptors and P2X 4 receptors.
Rat cholangiocytes express multiple P2Y subtypes at apical plasma membrane. Experiments were performed in IBDUs to determine which of these P2Y receptors were expressed at the apical membranes. IBDUs were mounted on a specially designed stage for visualization on a fluorescence microscope ( Fig. 2A) . Because P2Y receptors couple to phospholipase C (PLC)-and inositol trisphosphate (InsP 3 )-mediated increases in Ca i 2ϩ , Ca i 2ϩ was monitored to indicate P2Y receptor activation. IBDUs were loaded with the Ca 2ϩ -sensitive dye fluo 4-AM by luminal perfusion with the dye (Fig. 2B) . Subsequent luminal perfusion with nucleotides induced serial increases in fluo 4 fluorescence, reflecting increases in Ca i 2ϩ (Fig. 2C) . These findings suggest that P2Y receptors are expressed on the apical membrane of bile duct cells.
To verify that Ca i 2ϩ increases induced by luminal nucleotides were specific to P2Y receptor activation, experiments were performed in the presence of either the ATP diphosphohydrolase apyrase or the P2Y inhibitor suramin (Fig. 3) . ATP (100 M) increased fluo 4 fluorescence by 78 Ϯ 10% (n ϭ 5), whereas ATP (100 M) ϩ apyrase (3 U/ml) increased fluorescence by only 5 Ϯ 0.8% (n ϭ 5; P Ͻ 0.01 by 1-tailed t-test), and ATP (100 M) ϩ suramin (50 M) increased fluorescence by only 9 Ϯ 2.7% (n ϭ 5; P Ͻ 0.02 by 1-tailed t-test). These findings demonstrate that increases in Ca i 2ϩ induced by luminal perfusion of nucleotides are caused by activation of apical P2Y receptors.
To determine whether apical cholangiocyte P2Y receptors are activated in a concentration-sensitive fashion, we perfused IBDUs with ATP at a concentration range of 10 nM-1 mM. Perfusion with 10 nM ATP did not increase fluo 4 fluorescence; 100 nM ATP increased fluo 4 fluorescence by ϳ22%; 1 M and 10 M ATP increased fluo 4 fluorescence by 41% and 46%, respectively; and 100 M ATP increased fluo 4 fluorescence by ϳ88% and was the maximum concentration of ATP found to increase fluo 4 fluorescence. Perfusion with 1 mM ATP decreased fluo 4 fluorescence by ϳ5%. This may have been caused by hyperstimulation of G protein-coupled receptors leading to nonspecific G protein cross talk (32) or, alternatively, by acidification of the cytosol and subsequent pH-dependent decrease in fluo 4 fluorescence (Molecular Probes). Together, these findings suggest that cholangiocytes are sensitive to Fig. 1 . A: rat cholangiocytes express P2Y receptor subtypes P2Y1, P2Y2, P2Y4, and P2Y6. Molecular expression of P2Y subtypes by rat cholangiocytes was evaluated by RT-PCR. Cholangiocytes were immunoisolated, and RNA was extracted. Cholangiocyte cDNA was exposed to specific oligonucleotide primers for P2Y1 (lane 1), P2Y2 (lane 2), P2Y4 (lane 3), and P2Y6 (lane 4). Bands of predicted molecular weight are found for each subtype but not in RNA controls not exposed to reverse transcriptase (Ϫ, lanes [5] [6] [7] [8] . Positive bands were gel excised and sequenced and were found to have 100% identity to published sequences. B: rat cholangiocytes express the P2X receptor subtype P2X4. Molecular expression of subtypes P2X1-7 was examined using RT-PCR of immunoisolated rat cholangiocytes using specific oligonucleotide probes (P2Y2 oligonucleotides were used as a positive control in lane 2). Cholangiocytes expressed subtype P2X4. Positive bands were found in total liver (P2X1-7) and heart (P2X1,2,4,5).
ATP over the range 100 nM-100 M, which includes the concentrations of nucleotides found in bile (9) .
To investigate whether apical cholangiocyte membranes express multiple subtypes of P2Y receptors, we perfused IBDUs with nucleotides that are specific to each particular P2Y receptor subtype. ATP, ADP, 2-MeS-ATP, UTP, and UDP each increased fluo 4 fluorescence by 41 Ϯ 4 to 62 Ϯ 11% at concentrations of 1-10 M and by 88 Ϯ 20 to 100 Ϯ 22% at a concentration of 100 M (Fig. 4B) . Pretreatment of ducts with ATP, ADP, UTP, or UDP had no effect on subsequent nucleotide responses (ATP, n ϭ 6; ADP, n ϭ 6; UTP, n ϭ 7; UDP, n ϭ 7). Because ADP, ATP, and 2-MeS-ATP act at the P2Y 1 receptor, UTP and ATP act at the P2Y 2 and P2Y 4 receptors, and UDP acts at the P2Y 6 receptor, these findings suggest that rat cholangiocytes express all four of these P2Y subtypes at the apical membrane. Because nucleotide pretreatment had no effect on subsequent nucleotide responses, this suggests that these responses to different nucleotides are mediated by expression of multiple P2Y receptor subtypes rather than nucleotide interconversion.
Rat cholangiocytes express P2Y receptors at basolateral plasma membrane. Additional experiments were performed in IBDUs to investigate whether P2Y receptors are expressed at the basolateral membranes of cholangiocytes. The presence of basolateral P2Y receptors was investigated by addition of nucleotides to the perifusing bath. ACh was used as a positive control because cholangiocytes are known to express M 3 muscarinic receptors at the basolateral membrane (2, 29) . ACh (100 M) increased fluo 4 fluorescence by 24 Ϯ 1% (n ϭ 4; P Ͻ 0.05 vs. ATP), but only minimal increases in fluorescence (2-10%) were evoked by ATP (100 M; n ϭ 5), ADP (100 M; n ϭ 5), UTP (100 M; n ϭ 5), or UDP (100 M; n ϭ 5). However, basolateral addition of the nonhydrolyzable ATP analog ATP-␥-S (100 M) increased fluo 4 fluorescence by 30 Ϯ 2% (n ϭ 3; P Ͻ ) increase in an IBDU. A 100-m pinhole was placed over an intracellular area of fluorescence, and then serial changes in fluorescence were monitored over time. Fluo 4 fluorescence remains stable during perfusion with buffer alone, but a rapid increase in fluo 4 fluorescence is seen after addition of ATP (100 M). Similar findings were seen with 2-methylthioadenosine 5Ј-triphosphate (2-MeS-ATP), ADP, UDP, and UTP. f/f0, Peakto-baseline fluorescence ratio. Fig. 3 . Ca i 2ϩ increases induced by apical nucleotides result from activation of P2Y receptors. Apical P2Y receptors were activated as described in Fig. 2 with ATP (100 M), ATP (100 M) ϩ apyrase (3 U/ml), or ATP (100 M) ϩ suramin (50 M). ATP alone nearly doubled fluo 4 fluorescence, whereas fluorescence was increased only minimally by ATP in the presence of the ATP diphosphohydrolase apyrase or the P2Y receptor antagonist suramin. *P Ͻ 0.01, **P Ͻ 0.02 vs. ATP by 1-tailed t-test. Similar findings were seen on stimulation with 2-MeS-ATP, ADP, UDP, and UTP (not shown).
0.05 vs. ATP), similar to the increase induced by ACh (Fig. 5) . The lowest concentration of ACh that induced an increase in fluo 4 fluorescence was 10 M, consistent with previous observations in cholangiocytes (29) , whereas the lowest concentration of ATP-␥-S that induced an increase in fluo 4 fluorescence was 1 M. The effect of ATP-␥-S was inhibited by both the P2Y antagonist suramin (50 M) and the Ca i 2ϩ chelator BAPTA-AM (50 M).
Together, these data suggest that cholangiocytes express P2Y receptors at the basolateral membrane, but activation of these receptors by ATP and other nucleotides is attenuated in part by hydrolysis of nucleotides. Moreover, the decreased effect of basolateral ATP-␥-S (relative to apical nucleotides) suggests that the potency of nucleotides at the basolateral membrane is weaker than at the apical membrane. Therefore, expression of P2Y receptors at the basolateral plasma membrane may be lower than that at the apical membrane. Alternatively, apical P2Y receptors may couple more strongly to G proteins that link to PLC and InsP 3 formation (31) . A final possibility is that the unique ability of basolateral ATP-␥-S to induce a relatively weak Ca i 2ϩ transient is caused by phosphatase-resistant thiophosphorylation reactions catalyzed by ectokinases rather than activation of basolateral nucleotide receptors. Direct measurement of basolateral ectonucleotidase activity would be needed to distinguish among these possible explanations.
Functional expression of P2X receptors in rat cholangiocytes. Functional expression of P2X receptors was examined using P2X-specific synthetic nucleotides ␣,␤-MeATP (P2X agonist most potent at P2X 1 and P2X 2 ), ␤,␥-MeATP (P2X agonist most potent at P2X 1 ), and BzATP (P2X agonist most potent at P2X 1 and P2X 7 ) (Fig. 6) (30) . Stimulation of IBDUs with these agonists at either the apical or basolateral membrane induced minimal changes (Ϫ6% to ϩ8%) in Ca i
2ϩ , yet apical perfusion with ATP as a positive control yielded Ca i 2ϩ increase of 46 Ϯ 6.8%, similar to what was seen in prior experiments. These data suggest that, although rat cholangiocytes express the P2X receptor subtype P2X 4 , they do not express P2X subtypes sensitive to P2X- Fig. 4 . Multiple P2Y receptor subtypes are expressed on apical cholangiocyte membranes. A: concentration-response curve for apical stimulation with ATP. Apical P2Y receptors were activated as described in Fig. 2 for ATP at concentrations of 10 nM-1 mM. The lowest concentration to activate apical ATP receptors was 100 nM, and the greatest concentration to activate apical P2Y receptors was 100 M. The apparent lack of response at 1 mM may be caused by activation of other G protein-coupled receptor systems or by loss of fluo 4 fluorescence caused by changes in cell pH. B: comparison of nucleotide responses for apical nucleotides. Concentration responses were determined for the nucleotides 2-MeS-ATP, ADP, ATP, UDP, and UTP at concentrations of 1, 10, and 100 M. At 1-10 M, all nucleotides induced a similar increase in fluo 4 fluorescence. At 100 M, all nucleotides induced a much greater increase in fluo 4 fluorescence. Nucleotide-induced increases in fluo 4 fluorescence were roughly equal for each nucleotide at each concentration. Together, these data suggest that apical cholangiocyte membranes express the P2Y receptor subtypes P2Y1, P2Y2 or P2Y4, and P2Y6. specific nucleotides. Because there are no specific agonists available for the P2X 4 receptor, the polarity of its expression cannot be established.
Activation of bile duct epithelial P2Y receptors induces bile duct alkalization. To determine the functional role of cholangiocyte P2Y receptors in fluid and electrolyte secretion, changes in biliary pH were monitored after addition of ATP-␥-S to either the apical or the basolateral cell surface (Fig. 7) . ATP-␥-S was used to eliminate the role of nucleotide hydrolysis seen in Fig. 5 . Apical perfusion of ATP-␥-S (100 M) induced a net increase in biliary pH of 0.32 Ϯ 0.078 units (P ϭ 0.039). Basolateral perfusion of ATP-␥-S (100 M) induced a trend toward increase in biliary pH of 0.10 Ϯ 0.019 units (P ϭ 0.058). The finding that apical ATP-␥-S induced a larger increase in pH than basolateral ATP-␥-S is consistent with the difference in Ca i 2ϩ increases seen with these agonists. For comparison, stimulation with a maximal concentration of forskolin increases luminal pH by ϳ0.6 units in this experimental system (27) . These experiments demonstrate that nucleotide signaling may contribute to regulation of HCO 3 Ϫ secretion in bile duct epithelia.
DISCUSSION
The role of extracellular nucleotides as signaling molecules has now been shown in many tissue types (15, 28, 42, 46) . A specific role for nucleotides and their , whereas ATP (100 M, apically applied) induced an increase comparable to that seen in Fig. 4 . receptors in liver, and in cholangiocytes in particular, has been demonstrated in several ways. First, hepatocytes can signal to cholangiocytes over distances of several hundred micrometers through nucleotide release, suggesting that P2Y receptors allow paracrine signaling between these two liver cell types (39) . Second, nucleotides are found in nanomolar to micromolar concentrations in bile, suggesting that purinergic signaling from hepatocytes to cholangiocytes may occur through release of nucleotides into bile (9) . Third, expression of nucleotide receptors by bile duct-derived cell lines is critical for autoregulation of cell volume, demonstrating that P2Y receptors are important in autocrine signaling in these cells (35) . Finally, bile duct-derived cell culture models express apical P2Y receptors, which would be necessary for activation by nucleotides released into bile (36, 38) . Together, these observations show an important potential role for purinergic signaling through P2Y receptors in bile ductular signaling. However, previous studies failed to address several key questions. First, the distribution and relative roles of the different subtypes of P2Y receptors found in cholangiocytes were unknown. The various subtypes of P2Y receptors expressed in rat and other mammals differ not only in molecular structure but also in nucleotide pharmacological preference. Here we found that rat cholangiocytes express all four of the P2Y subtypes previously identified in this species. Thus these cells can be activated not only by ATP but also by a variety of nucleotides. This finding is important for several reasons. First, multiple P2Y subtypes have been cloned only in the past few years. Although these receptors share common tertiary structure and function, their primary structures vary greatly. A precise understanding of P2Y receptor tissue distribution would facilitate design of pharmacological agonists or antagonists for these receptors. Moreover, endogenously occurring nucleotides found in body fluids include not only adenosine nucleotides but uridine nucleotides as well (21) . Because all nucleotides are equipotent in cholangiocyte activation, it is possible that those nucleotides are also involved in signaling responses for these cells.
A second question that has been addressed in the present study is the distribution of P2Y receptors in native cholangiocytes in particular. Although the demonstration of P2Y receptors has been examined in cholangiocyte cell lines (36, 38) , cell lines in general have been inaccurate as models of P2Y receptor expression. Specifically, it has been found that expression and polarized distribution of P2Y receptor subtypes depends on both number of days in culture and cell support mechanisms (18) . In fact, the NRC bile duct cell line appears to express only P2Y 2 receptors at the apical membrane (38), whereas we report here that native cholangiocytes also express P2Y 1 , P2Y 4 , and P2Y 6 apically. Thus cell culture models may provide an insufficient means to determine the polarized distribution of P2Y receptor subtypes in native tissues. In the liver, this is of critical import-if receptors are expressed apically, they are activated by nucleotides released directly into bile, whereas if they are expressed basolaterally, they are activated by nucleotides released into blood or by nerves. Our finding that P2Y receptors are expressed both apically and basolaterally shows that each mechanism may be operative in bile duct epithelia. Our finding that basolateral nucleotide signaling is attenuated at least in part by nucleotide hydrolysis is consistent with the observation that ATP degradation is biphasic during basolateral exposure to NRC cells (36) . This also suggests that nucleoside triphosphate diphosphohydrolases may be localized to the basolateral membranes of cholangiocytes rather than to nearby cells or interstitium. Because nucleotides appear to be degraded more quickly basolaterally, P2Y receptor activation at this plasma membrane domain may be more important for autocrine signaling, whereas activation of apical P2Y receptors may be more important for paracrine signaling (Fig. 8) .
Because P2Y receptor activation can induce Cl Ϫ and HCO 3 Ϫ secretion independent of CFTR, these receptors are an attractive therapeutic target in secretory disorders such as CF. In fact, nucleotides activate Cl Ϫ currents in multiple tissues affected by CF, including respiratory, reproductive, and digestive epithelia (7, 12, 24, 26, 41, 48) . In cholangiocytes, both CFTR and P2Y-activated non-CFTR Cl Ϫ channels are thought to induce bulk fluid and electrolyte secretion through apical Cl Ϫ /HCO 3 Ϫ exchange, duct alkalization, and paracellular water movement. Furthermore, second messengers such as cAMP and Ca i 2ϩ may induce ATP release (5, 6, 9) and thereby activate P2Y-mediated secretion. Activation of Ca 2ϩ -sensitive Cl Ϫ channels and subsequent Cl Ϫ /HCO 3 Ϫ exchange is a likely mechanism for nucleotide-induced bile duct alkalization. However, duct alkalization may also work through direct HCO 3 Ϫ export (11, 14) . Furthermore, studies in the intact, bivascularly perfused liver suggest that regulation of biliary HCO 3 Ϫ excretion may be the principal function of cholangiocytes in vivo (17) . The current work provides evidence that apical stimulation with nucleotides may thus have the same physiological effect as basolateral stimulation with secretin or ACh (17) . The mechanism by which extracellular nucleotides regulate bile duct alkalization should provide a robust area for further research that may provide insights into the pathogenesis of CF and other cholestatic conditions in which cholangiocytes are the target of disease.
